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Staphylococcus epidermidis biofilm formation is associated with the production of the polysaccharide intercellular adhesin (PIA)--poly-N-acetylglucosamine polysaccharide (PNAG) by the products of the icaADBC
operon. Recent evidence indicates that SarA, a central regulatory element that controls the production of
Staphylococcus aureus virulence factors, is essential for the synthesis of PIA/PNAG and the ensuing biofilm
development in this species. Based on the presence of a sarA homolog, we hypothesized that SarA could also
be involved in the regulation of the biofilm formation process in S. epidermidis. To investigate this, we
constructed nonpolar sarA deletions in two genetically unrelated S. epidermidis clinical strains, O-47 and
CH845. The SarA mutants were completely defective in biofilm formation, both in the steady-state conditions
of a microtiter dish assay and in the flow conditions of microfermentors. Reverse transcription-PCR experiments showed that the mutation in the sarA gene resulted in downregulation of the icaADBC operon transcription in an IcaR-independent manner. Purified SarA protein showed high-affinity binding to the icaA
promoter region by electrophoretic mobility shift assays. Consequently, mutation in sarA provoked a significant
decrease in the amount of PIA/PNAG on the cell surface. Furthermore, heterologous complementation of S.
aureus sarA mutants with the sarA gene of S. epidermidis completely restored biofilm formation. In summary,
SarA appeared to be a positive regulator of transcription of the ica locus, and in its absence, PIA/PNAG
production and biofilm formation were diminished. Additionally, we present experimental evidence showing
that SarA may be an important regulatory element that controls S. epidermidis virulence factors other than
biofilm formation.

epidermidis that differs between invasive strains and strains
from the skin flora (15, 16).
PIA/PNAG production and biofilm formation in S. epidermidis are regulated by a variety of environmental factors, including high osmolarity (3% NaCl), ethanol (4%), glucose,
growth in anaerobic conditions, high temperature, and subinhibitory concentrations of certain antibiotics (7, 10, 12, 27, 28).
Genetic regulation involving icaR and the alternative sigma
factor B has been reported. The gene icaR, located adjacent
to the ica operon, encodes a transcriptional repressor involved
in the environmental regulation of icaADBC operon expression in S. epidermidis and S. aureus (8, 24, 25). A transcriptional
analysis revealed that icaADBC transcription was strongly repressed in mutants with defective B, whereas icaR was upregulated, a finding suggesting that B controls transcription of
the icaADBC operon by an icaR-dependent pathway in S. epidermidis (27, 28). However, the alternative transcription factor
B plays contradictory roles in controlling biofilm formation of
S. aureus. While an initial work by Rachid and coworkers
implied that B was a regulator of the biofilm formation process of S. aureus (42), our results have demonstrated that
biofilm and PIA/PNAG production were not affected in a S.
aureus B mutant compared with its wild-type strain (47).
Moreover, ica operon expression in S. epidermidis can be
turned on and off by the insertion and excision of the insertion
sequence IS256 at specific hot spots in the icaA and icaC genes

Chronic nosocomial infections by biofilm-forming Staphylococcus epidermidis have become more prevalent in recent years
with the increased use of prosthetic medical implants. Biofilm
formation by S. epidermidis frequently compromises the effectiveness of implanted medical devices by giving rise to persistent and relapsing infections, which are more resistant to the
host immune response and antimicrobial chemotherapy (for a
review, see reference 18). The formation of S. epidermidis
biofilms is proposed to occur in a two-step manner, in which a
cellular accumulation process to form the mature biofilm follows rapid initial attachment to an inert synthetic surface (22).
Critical to S. epidermidis biofilm formation is the production of
a poly-N-acetylglucosamine polysaccharide (PNAG)-polysaccharide intercellular adhesin (PIA) (33, 34). The intercellular
adhesin (icaADBC) locus, originally described in S. epidermidis
(22, 23) and later found in Staphylococcus aureus (9), contains
the genes involved in PIA/PNAG production. The significance
of PIA/PNAG as a virulence factor was demonstrated in a
central venous catheter infection model of a rat and in a
subcutaneous foreign-body infection model in mice (43, 44). In
addition, the ica operon is one of the few genetic markers of S.
* Corresponding author. Mailing address: Instituto Valenciano de
Investigaciones Agrarias (IVIA), Universidad Cardenal Herrera-CEU,
Carretera Náquera-Moncada, Km 4,5. 46113, Moncada, Valencia,
Spain. Phone: 34 96 34 24 007. Fax: 34 96 34 24 001. E-mail: jpenades
@ivia.es.
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TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid

Strains
RN4220
15981
15981 ⌬ica
15981 ⌬sarA
ISP479c
ISP479c sarAO-47
O-47 ⌬ica::tet
CH845
JP54
JP55
JP56
JP57
JP58
JP59
Plasmids
pCU1
pMAD

Species

S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.
S.

aureus
aureus
aureus
aureus
aureus
aureus
epidermidis
epidermidis
epidermidis
aureus
aureus
epidermidis
epidermidis
epidermidis
epidermidis

pJP18
pJP19

Relevant properties

Source or
reference

Restriction-deficient mutant of 8325-4
Clinical isolate, biofilm-positive
Derivative of 15981; icaADBC-negative, biofilm-negative strain
Derivative of 15981; sarA-negative, biofilm-negative strain
Derivative of 8325; biofilm-positive strain
Derivative of ISP479c; sarA-negative; biofilm-negative strain
Clinical strain; icaADBC-positive; biofilm-positive strain
Derivative of O-47; icaADBC mutant; biofilm-negative strain
Clinical strain BM94314; icaADBC-positive; biofilm-positive strain
15981 ⌬sarA(pJP19)
ISP479c sarA(pJP19)
Derivative of O-47; sarA mutant
Derivative of CH845; sarA mutant
JP56(pJP19)
JP57(pJP19)

29
47
47
47
40
47
22
10
16
This
This
This
This
This
This

Shuttle plasmid
Shuttle vector with a termosensitive origin of replication for
gram-positive bacteria
Derivative of pMAD used to construct the deletions in the sarA
gene
Vector for complementation experiments; a 1.1-kb PCR fragment
containing sarA from S. epidermidis RP62A cloned in pCU1

2
1

(51). By this mechanism, PIA/PNAG production and biofilm
formation phenotypes may be phase variable.
By screening a library of Tn917 insertions in a clinical S.
aureus strain, we identified SarA as being essential for biofilm
development by S. aureus (47). Nonpolar mutations of sarA in
genetically unrelated S. aureus strains decreased ica transcription and PIA/PNAG production and completely prevented
biofilm development. In S. epidermidis, a SarA protein has
been described (14). This protein is highly related (84%) to the
S. aureus SarA protein, suggesting that it could be involved in
the control of virulence determinants. However, no data on sar
regulation exist, and some evidence suggests the existence of
particularities for each species. Thus, the order of the three
promoters that control sarA expression is not the same in S.
epidermidis as in S. aureus, a distinction which might reflect
differences in regulation (14).
In this study, we have examined the role of SarA in the
regulation of icaADBC operon expression, PIA/PNAG production, and biofilm formation in two genetically unrelated
biofilm-positive clinical isolates of S. epidermidis. Our results
demonstrate that the sarA mutants show a severe defect in
biofilm formation through a transcriptional downregulation of
icaADBC operon expression and PIA/PNAG production by an
IcaR-independent pathway.
MATERIALS AND METHODS
Bacterial strains, culture conditions, and plasmids. The biofilm-forming
strain S. epidermidis O-47 was isolated from a patient at the Institut für Medizinische Mikrobiologie und Hygiene, Universität zu Köln, Cologne, Germany
(22). S. epidermidis CH845 was isolated from a patient with infection in a joint
prosthesis (16). Both strains were selected because of their strong biofilm production phenotype, antibiotic susceptibility profile, and ability to accept recombinant DNA by protoplast transformation.
The most relevant bacterial strains and plasmids used and constructed in this
study are listed in Table 1. Escherichia coli DH5␣ cells were grown in Luria-

study
study
study
study
study
study

This study
This study

Bertani (LB) broth or on LB agar (Pronadisa) with appropriate antibiotics.
Staphylococcal strains were cultured on Trypticase soy agar (TSA), in Trypticase
soy broth supplemented with glucose (0.25% wt/vol; TSB-gluc), and in Congo red
agar (11). Media were supplemented with appropriate antibiotics in the following
concentrations: erythromycin, 2.5 g/ml; ampicillin, 100 g/ml; and chloramphenicol, 20 g/ml.
DNA manipulations. Routine DNA manipulations were performed with standard procedures (45) unless otherwise stated. Plasmid DNA from E. coli and
staphylococci were purified with a Genelute plasmid miniprep kit (Sigma) according to the manufacturer’s protocol, except that the staphylococcal bacterial
cells were lysed by lysostaphin (Sigma; 12.5 g/ml) at 37°C for 1 h before plasmid
purification. Plasmids were introduced into the staphylococci by electroporation
or by protoplast transformation with previously described methods (11, 19, 20).
Restriction enzymes were purchased from Roche and used according to the
manufacturer’s instructions. Oligonucleotides were obtained from Invitrogen
(Table 2).
Staphylococcal chromosomal DNA was extracted with a Genelute bacterial
genomic DNA kit (Sigma) according to the manufacturer’s protocol, except that
the bacterial cells were lysed by lysostaphin (Sigma; 12.5 g/ml) at 37°C for 1 h
before DNA purification. For Southern blot hybridization, the chromosomal
DNA digested with HindIII was analyzed by agarose gel electrophoresis. Gels
were blotted onto nylon membranes (Hybond-N 0.45-mm-pore-size filters, Amersham Life Science) with standard methods (3, 45). The PCR product of the
amplified sarA gene with oligonucleotides Sarepi-5c and Sarepi-8c was used as a
DNA probe. Labeling of the probe and DNA hybridization were performed
according to the protocol supplied with the PCR-DIG DNA-labeling and chemiluminescent detection kit (Roche).
Allelic exchange of chromosomal genes. To construct the deletions in sarA, we
amplified by PCR two fragments of approximately 1,000 bp that flanked the left
(oligonucleotides Sarepi-4cB and Sarepi-3m) and the right (oligonucleotides
Sarepi-2c and Sarepi-1mX) of the sequence targeted for deletion (Table 2).
Oligonucleotides Sarepi-2c and Sarepi-3m have a 20-base complementary region
(underlined in the oligonucleotide sequence) to allow the products of the first
PCR to anneal at their overlapping region. A second PCR was performed with
primers Sarepi-1mX and Sarepi-4cB to obtain a single fragment. Specifically, 1 l
of each of the products of the first PCR was mixed with 10 pM of the outside
primers and PCR amplified. The fusion products were purified and cloned into
the BamHI and XbaI sites of plasmid pSC20 (F. Götz). The fragment was then
cloned into the SalI and EcoRI sites of the shuttle plasmid pMAD (1), and the
resulting plasmid, pJP18, was transformed into S. epidermidis by protoplast
transformation. Plasmid pMAD contains a temperature-sensitive origin of rep-
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TABLE 2. Oligonucleotides used in this study

Oligonucleotide

Sarepi-1mX
Sarepi-2c
Sarepi-3m
Sarepi-4cB
Sarepi-5c
Sarepi-6cX
Sarepi-7mB
Sarepi-8c
icaA-epi-1
icaA-epi-2
icaR-epi-1
icaR-epi-2
icaR-aur-1c
icaA-aur-3c
icaR-epi-7c
icaA-epi-3
gyrB-epi-1
gyrB-epi-2

Sequence (5⬘-3⬘)

TGCTCTAGAATGACTAAAGGGAGGTGCC
GGCTAGGGAGTAAAACAGATATTTC
ATCTGTTTTACTCCCTAGCCGCAATGTAGC
ATTTGCTATATTC
CGCGGATCCTAAATTAACTTCTAAAACA
GAAG
TGGATATGATATAAATAGGGAGG
TGCTCTAGAGGACATGCACCACATATC
GAGG
CGCGGATCCGGTATATTAATATAACTAA
AGGC
TCTGTGATACGGTTGTTTACTCG
AACAAGTTGAAGGCATCTCC
GATGCTTGTTTGATTCCCT
GGTAAAGTCCGTCAATGGAA
CGCAATAACCTTATTTTCCG
ATTGCGTTATCAATAATCTTATC
TTGCAATTTCTTTACCTACCTTTCG
ATTGCGTTATCAATAATCTTATC
CATGCATTTTTTCACCTACCTTTCG
TTATGGTGCTGGACAGATACA
CACCGTGAAGACCGCCAGATA

lication and an erythromycin resistance gene. The plasmid was integrated into
the chromosome through homologous recombination at the nonpermissive temperature (43.5°C). From the 43.5°C plate, one to five colonies were picked into
10 ml of TSB-gluc and incubated for 24 h at 30°C. Tenfold serial dilutions of this
culture in sterile TSB-gluc were plated on TSA containing 5-bromo-4-chloro-3indolyl-B-D-galactopyranoside at 150 g ml⫺1). White colonies, which no longer
contained the pMAD plasmid, were tested to confirm the replacement by PCR
with oligonucleotides Sarepi-1mX and Sarepi-5c (Table 2) and by Southern
blotting.
Complementation of the mutants. The sarA gene from S. epidermidis RP62A
was amplified with high-fidelity thermophilic DNA polymerase (Dynazyme Ext,
Finnzymes) with primers Sarepi-7mB and Sarepi-6cX (Table 2). The PCR product was cloned into the BamHI and XbaI sites of the pCU1 plasmid (2), and the
resulting plasmid, pJP19, was transformed by electroporation or protoplast transformation into S. aureus RN4220 or S. epidermidis strains. Phage 80␣ was used to
transduce pJP19 from RN4220 to strains 15981 and ISP479c (39).
Biofilm formation assays. The quantification of the biofilm formation on
abiotic surfaces was assessed basically as described elsewhere (11, 22). Macroscopic observation of biofilm on glass was performed as previously described
(11). Briefly, cells were grown in 50 ml of B2 at 37°C, with a glass container,
without shaking, for 1 day, and the walls of the container were visually (macroscopically) examined for the presence or absence of a white biofilm layer.
To analyze biofilm formation under flow conditions, we used 60-ml microfermenters (Pasteur Institute’s Laboratory of Fermentation) with a continuous flow
of 40 ml h⫺1 of TSB-gluc and constant aeration with sterile compressed air (0.3
bar). Submerged Pyrex slides served as the growth substratum. Approximately
108 bacteria from an overnight preculture of each strain grown in TSB-gluc were
used to inoculate the microfermenters and cultivated 24 h at 37°C. Biofilm
development was recorded with a Nikon Coolpix 950 digital camera.
PNAG detection. PNAG production in the S. epidermidis strains was detected
as described elsewhere (9), with an anti-S. aureus PNAG antibody diluted
1:10,000 (34). Bound antibodies were detected with a peroxidase-conjugated
goat anti-rabbit immunoglobulin G antibody (Santa Cruz) diluted 1:5,000, and
the Western blotting Luminol reagent (Santa Cruz Biotechnology).
Real-time quantitative PCR. Total S. epidermidis RNA was prepared with the
Fast RNA-Blue kit (Bio 101) according to the manufacturer’s instructions. Two
micrograms of each RNA was subjected, in duplicate, to DNase I (Invitrogen)
treatment for 30 min at 37°C. The enzyme was inactivated at 65°C in the presence
of EDTA. To verify the absence of genomic DNA in every sample, the RNA
duplicates were reverse transcribed in the presence and absence of Moloney
murine leukemia virus reverse transcriptase (Invitrogen). All preparations were
purified with the QIAquick PCR purification kit (Qiagen); 25 ng of each reaction
product was used for a real-time quantitative PCR with the iCycler machine
(Bio-Rad) and the LC-DNA Master SYBR Green I mix (Bio-Rad). The icaA

and icaR transcripts were amplified with primers icaA-epi-1/icaA-epi-2 and icaRepi-1/icaR-epi-2, respectively (Table 2). The gyrB transcripts that are constitutively expressed were amplified as an endogenous control with the primers
gyrB-epi-1 and gyrB-epi-2 (Table 2). The level of expression of icaA was normalized with respect to gyrB expression. Only samples with no amplification of
gyrB in the minus-reverse transcriptase aliquot were included in the study.
To monitor the specificity, the final PCR products were analyzed by melting
curves and electrophoresis. In each experiment, all the reactions were performed
in triplicate. The relative transcriptional levels within distinct experiments were
determined with the 2⫺⌬⌬CT method (31). The results show the average ⫾
standard error of the mean of at least four independent experiments.
Purification of SarA protein. The cloning and purification of the His6-tagged
SarA fusion protein were described earlier (6). The purified His6-tagged SarA
protein was found to be more than 98% pure in a sodium dodecyl sulfate–12%
polyacrylamide gel. The concentration of the purified protein was determined by
the Bradford protein assay (Bio-Rad, Hercules, Calif.), with bovine serum albumin as the standard.
Electrophoretic mobility shift. To determine if the recombinant SarA protein
from S. aureus binds to the icaA promoter region, a 200-bp PCR-amplified
fragment, representing the icaRA intergenic region from S. aureus (oligonucleotides icaR-aur-1c and icaA-aur-3c) or S. epidermidis (oligonucleotides icaRepi-7c and icaA-epi-3) was end labeled with [␥-32P]ATP with T4 polynucleotide
kinase. Labeled fragment (0.1 ng or 0.5 fmol) was incubated at room temperature for 20 min with various amounts of purified SarA protein in 25 l of binding
buffer (25 mM Tris-Cl [pH 7.5], 0.1 mM EDTA, 75 mM NaCl, 1 mM dithiothreitol, and 10% glycerol) containing 0.5 g of calf thymus DNA (Amersham
Pharmacia Biotech). The reaction mixtures were analyzed in an 8.0% nondenaturing polyacrylamide gel. The band shifts were detected by exposing dried gels
to X-ray films.
Statistical analysis. The data indicating gene expression were compared with
the Kruskal-Wallis and the Mann-Whitney tests. All the tests were two-sided,
and the significance level was 5%. The statistical analysis was performed with the
SPSS program.

RESULTS
sarA gene of S. epidermidis restored the biofilm formation
capacity of the S. aureus ⌬sarA mutants. Considering the similarity of the SarA proteins of S. aureus and S. epidermidis, we
investigated the functional relationship of the sarA gene in
both species. The S. aureus sarA mutant clones 15981 ⌬sarA
and ISP479c sarA mutant (47) complemented with plasmid
pJP19 (carrying a PCR-amplified 1,109-bp fragment containing the sarA gene from S. epidermidis under the control of its
own promoter) were analyzed for their capacity to form a
biofilm. As shown in Fig. 1, we found that the complemented
strains JP54 and JP55 regained their capacity to form biofilms
compared with their respective sarA mutants. Evidently, the
SarA protein of S. epidermidis is functional in S. aureus.
Deletion of sarA in S. epidermidis resulted in a reduced
capacity to form a biofilm in vitro. To assess the role of SarA
in S. epidermidis, we constructed nonpolar deletions of the sarA
gene in two unrelated S. epidermidis clinical strains by allelic
exchange with the pMAD plasmid (see Materials and Methods). As shown in Fig. 2A and B, the deletion mutants JP56 (S.
epidermidis O-47 ⌬sarA) and JP57 (S. epidermidis CH845
⌬sarA) were reduced in their capacity to form a biofilm on
polystyrene microtiter plates compared to the wild-type parent
strains O-47 and CH845, respectively. When the JP56 strain
was complemented with plasmid pJP19, carrying the wild-type
sarA gene, biofilm formation was restored (Fig. 2A and B). In
contrast, although strain JP59 (JP57 carrying plasmid pJP19)
formed large clumps in broth cultures, it was unable to form a
biofilm on microtiter plates (data not shown). However, macroscopic examination of biofilm formation in a glass container
revealed that upon 1 day of culture, the wild-type (O-47 and
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FIG. 1. Biofilm formation phenotype of two unrelated S. aureus
sarA mutant clones carrying pJP19, a shuttle plasmid containing the
sarA gene from S. epidermidis. Biofilm formation capacity differences
correspond to 24-h biofilm formed on polystyrene microtiter plates
after staining with 0.1% safranin. The microtiter plates and mean
optical density values obtained (A495) are shown. (A) Left: wells corresponding to wild-type 15981, 15981 ⌬ica (negative control), 15981
⌬sarA, and JP54 (15981 ⌬sarA carrying pJP19). Right: wells corresponding to wild-type ISP479c, ISP479c ⌬sarA, and JP55 (ISP479c
⌬sarA carrying pJP19). (B) Mean optical density values. Bars represent
the mean values, and error bars represent the standard error of the
mean. Significant differences in adherence were noted between complemented and noncomplemented sarA mutant strains (*, P ⬍ 0.01).

CH845) and the complemented (JP58 and JP59) strains
formed an obvious biofilm on the glass surface, whereas the
sarA mutants JP56 and JP57 did not (Fig. 2C). These results
strongly suggest that the sarA gene is required for biofilm
formation in S. epidermidis.
Biofilm formation of the sarA mutants in continuous-flow
culture microfermenters. Extracellular proteases, including extracellular cysteine (Ecp) and serine (Esp) proteases, have
been described in S. epidermidis (13). The first enzyme shows
extended sequence similarity to the S. aureus cysteine protease
(staphopain), and the second resembles the serine protease
produced by that species. In S. aureus, the expression of the
extracellular proteases is repressed by SarA, since their production is upregulated in sarA mutants (5). In S. epidermidis,
nothing is known about their regulation, but it is likely that a
similar control by SarA occurs. To test that, the proteolytic
activity of the sarA mutant JP56 and JP57 strains and their
parental strains was analyzed on 1.5% skimmed milk agar
plates. As shown in Fig. 3A, the larger proteolytic halo around
the sarA mutant colonies of JP56 and JP57 compared with that
in the wild-type strains indicated an enhanced capacity of these
strains to produce extracellular proteases and suggested that
SarA is a repressor of protease production in S. epidermidis.
Thus, we wondered whether the decreased biofilm formation by the sarA mutant strains could be the consequence of the

FIG. 2. Loss of biofilm formation in two genetically unrelated S.
epidermidis sarA mutants. (A) Biofilm formation capacity of S. epidermidis O-47 and CH845 (wild-type strains), their corresponding sarA
mutants JP56 and JP57, the JP56 strain complemented with plasmid
pJP19 (JP58), and O-47 ⌬ica::tet as a negative control on polystyrene
microtiter plates after 24 h in TSB-gluc medium at 37°C. The bacterial
cells were stained with safranin and quantified by determining the
absorbance at 495 nm. (B) Significant differences in adherence were
noted between wild-type strains and their isogenic sarA mutants as well
as between the complemented versus noncomplemented JP56 (O-47
sarA mutant) strain (*, P ⬍ 0.05). (C) Phenotypic differences in the
capacity to form a 24-h biofilm on the surface of a glass container
(visual observation) between wild-type strains O-47 and CH845, their
corresponding sarA mutants (JP56 and JP57, respectively), and their
sarA mutants complemented with plasmid pJP19 (JP58 and JP59,
respectively).

accumulation of extracellular proteases in the microtiter plates
and the degradation of a surface protein required for biofilm
formation. To examine this possibility, we used microfermenters, where the medium is continuously replenished (17). As
shown in Fig. 3B, the wild-type strain O-47 adhered abundantly
to the submerged Pyrex spatula and, after 24 h, formed a thick
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FIG. 4. Loss of PNAG production in S. epidermidis sarA mutant
strains. Cell surface extracts from overnight cultures of S. epidermidis
wild-type strains O-47 and CH845, their corresponding sarA mutants
JP56 and JP57, respectively, the JP56 and JP57 strains complemented
with plasmid pJP19 (strains JP58 and JP 59, respectively), and the O-47
⌬ica::tet as a negative control, treated as described in Materials and
Methods, were spotted onto nitrocellulose filters. PNAG production
was detected with an anti-PNAG polyclonal antibody. The sarA mutants produced lower levels of PNAG product.

FIG. 3. (A) Increased protease production by S. epidermidis sarA
mutants. S. epidermidis wild-type strains O-47 and CH845 and their
corresponding sarA mutants were grown in skimmed milk agar plates.
(B) Biofilm formation in continuous-flow culture microfermenters of
S. epidermidis O-47 and its derivative sarA mutant JP56. Biofilm development in microfermenters (upper) or on the corresponding Pyrex
slides removed from the microfermenters (lower) after 24 h of growing
in TSB-gluc at 37°C is shown.

biofilm. In contrast, JP56 only formed microcolonies on the
surface of the slide and developed little biofilm thereafter.
Deletion of the sarA gene in S. epidermidis eliminates PIA/
PNAG production. The impact of the SarA regulator on the
production of PIA/PNAG, the product of the IcaADBC proteins, was initially investigated by a dot blot with a specific
anti-PNAG polyclonal antiserum (gift from G. Pier). The specificity of the polyclonal antiserum was confirmed by the absence of signal with the S. epidermidis O-47 ⌬ica::tet strain. Our
results showed that the JP56 and JP57 sarA mutants produced
decreased amounts of PNAG, whereas PNAG production was
restored in the complemented mutants JP58 and JP59 (Fig. 4).
SarA upregulates icaADBC expression. The results discussed above suggested that sarA might control biofilm formation through icaADBC expression. To investigate whether the
decrease in PIA/PNAG production observed in the sarA mutants was caused by a reduction of the icaADBC operon expression, we used real-time quantitative PCR. Although the
extent of the decrease in the icaA RNA levels was different in
both mutants, the results showed that the sarA mutation resulted in a significant (P ⬍ 0.05) decrease of icaADBC operon
transcription compared to that of the wild-type strains at the
mid-log exponential growth phase (OD650 ⫽ 1; Fig. 5). Similar

results were obtained with RNA purified at the early stationary
phase (OD650 ⫽ 2) (data not shown). These results indicate
that SarA is a transcriptional activator of the icaADBC operon.
However, it is worth noting the existence of considerable residual transcription of the icaADBC operon in the SarA mutant strain, a finding suggesting that SarA activity alone cannot
account for the total icaADBC operon expression.
Recombinant SarA binds to the icaA promoter region. As
the level of transcript of icaA was decreased in sarA mutants,
we speculated that SarA may bind to the icaA promoter region
to modulate icaADBC expression. To verify this, we employed
a 200-bp icaA promoter (from S. aureus or S. epidermidis) for
DNA binding assays. The DNA fragments were end labeled
with [␥-32P]ATP and used in gel shift assays with various
amounts of purified SarA protein (Fig. 6A). The retarded
protein-DNA complex could be detected with as little as 0.1 g
of SarA (⬇3.3 nM). As the concentrations of the SarA protein
increased, the retarded protein-DNA complex became the predominant band, with complete conversion at ⬇0.2 to 0.3 g of
SarA. The presence of shifted bands with different sizes sug-

FIG. 5. Real time quantification of ica expression on S. epidermidis
wild-type strains and their corresponding sarA mutants. Asterisks denote significance (P ⬍ 0.05).
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FIG. 6. Autoradiogram of a nondenaturing 8% polyacrylamide gel with purified SarA protein and a 198-bp ␥-32P-radiolabeled DNA fragment
containing the intergenic promoter region of the icaRA genes. A. Lanes 1 to 6, mobility of the 198-bp radiolabeled DNA fragment (⬇3 ng) of the
S. aureus icaRA promoters region in the presence of 0, 50, 100, 200, 300, and 500 ng of purified protein, respectively; lanes 7 and 8, mobility of
the same fragment with 300 ng of SarA, but in the presence of a 100-fold excess (molar ratio) of the unlabeled 198-bp fragment as the specific
competitor (lane 7) and a 100-fold excess of unlabeled 148-bp intergenic sarUT promoter fragment (36) as the nonspecific competitor (lane 8).
Lanes 9 to 16 are similar to lanes 1 to 8 except that the 198-bp fragment was from the ica promoter region of S. epidermidis. B. The nucleotide
sequence of the 198-bp fragment containing the ica intergenic region of S. aureus (AF086783) and S. epidermidis (U43366) is shown and marked
with the putative binding regions for SarA protein as determined based on the SarA consensus binding site (6).
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gests the existence of several SarA-binding sites into the
icaADBC promoter (Fig. 6B). Overall, these results support
that SarA can bind to the icaADBC promoter and act as an
activator of icaADBC transcription.
SarA does not affect icaR RNA levels. It has been reported
that mutation of either B or rsbU, an activator of B, results
in complete abolition of biofilm formation and a drastic decrease in S. epidermidis ica transcription (27, 28). A transcriptional analysis revealed that icaR is upregulated in these mutants lacking B functions; apparently, a B-dependent
regulatory intermediate negatively regulates IcaR. It has also
been shown that one of the sarA promoters (P1) is B dependent (14, 27). We therefore speculated that B might modulate
sarA expression and the ensuing ica transcription. If such an
association existed, expression of the icaR gene should be
increased in the sarA mutants. An analysis of the transcriptional activity of the icaR gene by real-time PCR showed that
the levels of icaR transcripts were not increased in the JP56
and JP57 sarA mutant strains (data not shown), a result suggesting control of the biofilm formation process by B- and
icaR-independent pathways.
DISCUSSION
Although the genetic arsenal responsible for pathogenesis
differs between S. aureus and S. epidermidis, both species are
capable of forming biofilms in a PIA/PNAG-dependent manner. In this context, a thorough comprehension of the mechanism by which PIA/PNAG is regulated in S. epidermidis and S.
aureus is an important prerequisite for understanding biofilm
formation and could ultimately lead to the development of
methods to repress the expression of this important virulence
factor. It is becoming increasingly apparent, however, that the
transcriptional regulation of the genes involved in PIA/PNAG
synthesis, the ica genes, is complex. This study provides experimental evidence to demonstrate that SarA regulates the expression of the ica operon in clinical isolates of S. epidermidis.
In S. aureus, the role of the SarA protein in pathogenesis has
been extensively analyzed with regard to its involvement in the
expression of extracellular and cell wall-associated virulence
determinants. In addition, we and others have recently reported that SarA is essential for biofilm development in S.
aureus (4, 47). However, little is known about the regulation of
virulence by SarA in S. epidermidis. Without the typical virulence determinants of S. aureus, S. epidermidis is a common
skin resident, the regulation of whose virulence determinants is
still largely unknown. The existence of a SarA homolog in S.
epidermidis encouraged us to examine whether SarA controls
biofilm formation in coagulase-negative staphylococci. The discovery that SarA controls this process, intimately related to the
persistence and antibiotic resistance of S. epidermidis infections, is a significant step in our initial approach toward understanding gene regulation in this pathogen.
Recently, in describing the role of B in S. epidermidis biofilm formation, Knobloch and coworkers presented a model of
the transcriptional and posttranscriptional regulation of PIA/
PNAG synthesis and accumulation in that organism (27). This
model revealed a complex regulation of PIA/PNAG synthesis,
involving at least three different regulatory pathways. Two of
these pathways act through the transcriptional regulation of

FIG. 7. Model of regulation of PIA/PNAG synthesis in S. epidermidis.

the negative regulator IcaR, and the third pathway is a glucosedependent proteinaceous factor of PIA/PNAG synthesis (12).
Based on our results, we proposed two additional pathways:
one depending on the global regulator SarA and the other
depending on the ␦-toxin, as previously described by Vuong
and coworkers (48) (Fig. 7).
Two lines of evidences indicated that the pathway used by
SarA in the control of icaADBC transcription is different from
that utilized by B. First, our results demonstrated that SarA
binds to the icaA promoter and that icaR transcription is not
increased in the SarA-defective strains in comparison to wildtype strains. In contrast, a B deficiency provokes an upregulation of icaR transcription. Second, Knobloch and coworkers
observed that supplementation of growth media with ethanol
decreased icaR transcription in a B mutant, a change leading
to increased icaA transcription and a biofilm-positive phenotype. However, in these growth conditions, the B-dependent
sarA transcript was absent in the B mutant, a finding suggest-
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ing that SarA did not influence the IcaR-dependent regulation
of PIA/PNAG synthesis (27). Furthermore, SarA influences
the regulation of biofilm formation via an agr-dependent pathway.
The gene for ␦-toxin is encoded within the gene for RNAIII,
and its expression is therefore directly linked to agr activity
(49). The agr two-component system does not affect the level of
icaADBC expression. However, probably because of its detergent-like physicochemical properties, the agr-encoded ␦-toxin,
when present, abolished biofilm-forming capacity in S. epidermidis (48). Interestingly, although the S. epidermidis O-47
strain used in this study has been described as a natural agr
mutant (48), deletion of the sarA gene in this strain inhibited
biofilm development. These data are consistent with the conclusion that SarA affects biofilm formation via an agr-independent pathway.
In addition, other potential regulators remain to be included
in this complex regulatory system. Two additional regulators,
tcaR and rbf, present in the genomes of the sequenced S.
epidermidis strains, have recently been described as being involved in S. aureus biofilm development. The tcaR gene is a
negative regulator of ica transcription, though deletion of tcaR
alone did not induce any changes in PIA/PNAG production or
in adherence to polystyrene (25). On the other hand, Rbf is
involved in the regulation of the multicellular aggregation step
of S. aureus biofilm formation in response to glucose and salt.
This regulation is probably mediated through a still-unidentified protein of 190 kDa (30). Finally, it is important to note
that several SarA homologs, involved directly or indirectly in
gene regulation, have been described in S. aureus. One of these
regulators, SarR, has been identified in S. epidermidis (50),
although is not present in all of the S. epidermidis strains
analyzed (35).
In S. aureus, SarR, a 115-residue polypeptide, represses
SarA expression during the postexponential phase by binding
to the sarA promoter region (35). If the function of the SarR
homolog in S. epidermidis is similar to that assigned in S.
aureus, it is tempting to speculate that, in a mature biofilm
colonizing medical devices, the expression of SarR by some
bacteria could turn off their biofilm formation capacities, so
that individual S. epidermidis cells could leave the biofilm and
colonize new surfaces.
Proteolytic enzymes are secreted by a large number of prokaryotic organisms. In most cases, they are involved in nutrient
acquisition, but a growing body of evidence indicates that peptidases produced by pathogenic bacteria are important virulence factors. In S. aureus, the expression of proteinases is
tightly regulated at the level of transcription by the global
regulators agr, sarA, and B (46). In addition, proteolytic activity is controlled at the posttranslational level by a cascade of
activation of the secreted zymogens. Both systems work in
concert to regulate the function of these enzymes, which are
suggested to facilitate S. aureus dissemination from initial colonization sites (32). This process occurs via an elaborate modification of bacterial surface proteins (26, 37, 38), changing the
bacterial phenotype from adhesive to invasive.
Similar to S. aureus, S. epidermidis ⌬sarA overproduces proteases. Evidence supports the implication of proteases in the
regulation of biofilm development. Thus, the inactivation of
gelE, encoding a zinc-metalloprotease gelatinase, prevents, by
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a still-uncharacterized mechanism, the primary attachment of
and biofilm development by Enterococcus faecalis (21). Furthermore, it has been demonstrated that the regulation of the
Hms phenotype of Yersinia pestis, involved in biofilm formation, results from the degradation of the HmsH, HmsR (homolog to IcaA), and HmsT proteins at 37°C (41).
In a previous study, we showed that inhibition or deletion of
the main proteases of S. aureus (aur and ssp) in a sarA-null
background was unable to restore biofilm formation. In this
study, we used microfermenters in which the continuous replenishment of medium might impair the accumulation of high
quantities of proteases in the growing extracellular medium.
However, we cannot rule out the accumulation of a protease in
the vicinity of the bacteria, a protease which, either by its
physical presence or by its enzymatic activity, could be responsible for the biofilm deficiency of both the S. epidermidis and S.
aureus strains. The cleavage of a surface protein could affect
the hydrophobicity of the bacterial surface and prevent its
attaching to surfaces such as plastic or glass. Alternatively, the
overproduction of proteases could result in the degradation of
Ica proteins responsible for PIA/PNAG synthesis. This rationale could explain the dissociation between residual icaADBC
transcription and the absence of PIA/PNAG production in
sarA mutants. In this context, it is important to note that
glucose-dependent posttranscriptional regulation of PIA/
PNAG synthesis has been described (12).
S. aureus and S. epidermidis are the gram-positive bacteria
most often associated with medical implant-related infections.
We have shown that both species control the PIA/PNAGdependent biofilm formation process via sarA and that deletion
of the sarA genes reduces the ability to produce PIA/PNAG
and form a biofilm in vitro. Due to the high level of morbidity
associated with S. epidermidis and S. aureus infections as well as
the high frequency of infection by both organisms, the sarA
gene could represent an important potential clinical target for
the prevention of chronic infections associated with prosthetic
medical devices.
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